Error assessment and correction for extrusion-based bioprinting using computer vision method.

Int J Bioprint

State Key Laboratory of Metal Matrix Composites, School of Material Science and Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.

Published: November 2022

AI Article Synopsis

  • * A new computer vision-based method has been developed to correct trajectory deviations in bioprinting, enhancing accuracy significantly.
  • * The study achieved a 91% correction efficiency and found that the correction results followed a normal distribution, indicating more reliable outcomes.

Article Abstract

299Bioprinting offers a new approach to addressing the organ shortage crisis. Despite recent technological advances, insufficient printing resolution continues to be one of the reasons that impede the development of bioprinting. Normally, machine axes movement cannot be reliably used to predict material placement, and the printing path tends to deviate from the predetermined designed reference trajectory in varying degrees. Therefore, a computer vision-based method was proposed in this study to correct trajectory deviation and improve printing accuracy. The image algorithm calculated the deviation between the printed trajectory and the reference trajectory to generate an error vector. Furthermore, the axes trajectory was modified according to the normal vector approach in the second printing to compensate for the deviation error. The highest correction efficiency that could be achieved was 91%. More significantly, we discovered that the correction results, for the first time, were in a normal distribution instead of a random distribution.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947486PMC
http://dx.doi.org/10.18063/ijb.v9i1.644DOI Listing

Publication Analysis

Top Keywords

reference trajectory
8
trajectory
5
error assessment
4
assessment correction
4
correction extrusion-based
4
extrusion-based bioprinting
4
bioprinting computer
4
computer vision
4
vision method
4
method 299bioprinting
4

Similar Publications

Background: Subjective Cognitive Decline (SCD) may represent the initial symptom of Alzheimer's disease (AD), but SCD may be absent and/or unrelated to actual cognitive decline. Objective Subtle Cognitive Decline (obj-SCD) can be identified through longitudinal standardized neuropsychological tests in individuals not yet meeting criteria for Mild Cognitive Impairment (MCI). We argue that the relationship between SCD and obj-SCD might help to inform clinical and research criteria in pre-MCI stages.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Cogstate Ltd., Melbourne, VIC, Australia.

Background: Cognitive dysfunction is central to clinicopathological models of Alzheimer's disease (AD). While AD prospective studies assess similar cognitive domains, the neuropsychological tests used vary between studies, limiting potential for aggregation. We examined a machine learning (ML) data harmonisation method for neuropsychological test data to develop a harmonised PACC score for the Alzheimer's Dementia Onset and Progression in International Cohorts (ADOPIC) consortium.

View Article and Find Full Text PDF

Background: Bilingualism and education have been known to enhance reserve/resilience through white matter (WM) microstructural changes. Reserve/resilience is the ability of the brain to cope with neurocognitive adversities. Two key hypotheses have been proposed under this framework.

View Article and Find Full Text PDF

Background: Agitation in dementia is associated with poor outcomes, including mortality. However, the lack of a consensus definition of agitation has hampered research, historically driven by variable approaches to symptom identification. Accordingly, prevalence estimates range widely (5%-88%) and interventions are hard to compare meaningfully.

View Article and Find Full Text PDF

Determinants and progression of stigma in amyotrophic lateral sclerosis/motor neuron disease.

Amyotroph Lateral Scler Frontotemporal Degener

January 2025

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

: Stigma in amyotrophic lateral sclerosis/motor neurone disease (ALS/MND) may be felt or enacted; felt stigma covers feeling devalued by the illness, whereas enacted stigma refers to being treated differently because of it. Stigma in ALS/MND has been shown to increase social withdrawal, worsen quality of life, and reduce use of assistive devices, so we explored prevalence and factors influencing stigma. : Participants in the Trajectories of Outcome in Neurological Conditions-ALS study completed scales measuring stigma, fatigue, spasticity, functioning, mood, worry, self-esteem, and perceived health, as well as demographic information and symptoms like head drop or emotional lability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!